🍃DEA Notice on Bulk Manufacturing of Controlled Substances
The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to its regulations governing the program of growing marihuana for scientific and medical research under DEA registration.
Learn More⚖️DEA Revocation of Joely Keen's Registration
The Drug Enforcement Administration has revoked Joely Keen's DEA registration after finding that she lacks the necessary state authority to handle controlled substances in Texas. This decision stems from the revocation of her nursing licenses and failure to maintain a prescriptive authority agreement, highlighting the importance of compliance in the healthcare field.
Learn More🌿DEA Notice
Maridose, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Learn More💊Notice of Pharmaron's Application for Controlled Substances Manufacturing
Pharmaron Manufacturing Services (US), LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Learn More💊Notice of Controlled Substances Import Application by Pharmaron
Pharmaron Manufacturing Services (US) LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Learn More🧪Notice of Bulk Manufacturer Application for Controlled Substances
Sterling Wisconsin, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Learn More📝DEA Registration Requirements and Compliance Notice
The Drug Enforcement Administration (DEA), Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Learn More💊Expansion of Buprenorphine Treatment via Telemedicine Regulations
In the January 17, 2025, issue of the Federal Register, the Drug Enforcement Administration and the Department of Health and Human Services published two final rules related to the practice of telemedicine, titled "Expansion of Buprenorphine Treatment via Telemedicine Encounter" and "Continuity of Care via Telemedicine for Veterans Affairs Patients." These final rules were originally scheduled to become final on February 18, 2025. In accordance with the Presidential Memorandum of January 20, 2025, titled "Regulatory Freeze Pending Review," the Drug Enforcement Administration and the Department of Health and Human Services delayed the effective dates of these two final rules to March 21, 2025, by issuing a final rule; delay of effective dates and request for comments in the February 19, 2025, issue of the Federal Register. The Drug Enforcement Administration received 32 comments in response to the request for public comments regarding the delayed effective date. Considering these comments, the Department of Justice wishes to further postpone the effective dates for the purpose of further reviewing any questions of fact, law, and policy that the rules may raise. Therefore, the Drug Enforcement Administration and the Department of Health and Human Services will delay the effective date of the two final rules titled "Expansion of Buprenorphine Treatment via Telemedicine Encounter" and "Continuity of Care via Telemedicine for Veterans Affairs Patients" to December 31, 2025.
Learn More⚖️DEA Revocation Order Impacting Texas Veterinarian Registration
The Drug Enforcement Administration (DEA) has issued a final order revoking the registration of Linwood A. Starks, D.V.M., due to his inability to practice veterinary medicine in Texas. The decision is based on the registrant's default following a suspension of his state veterinary license, highlighting the importance of state authority in maintaining a DEA registration for handling controlled substances.
Learn More💊Sterling Pharma's Application for Bulk Manufacturing of Controlled Substances
Sterling Pharma USA LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More